Short-term bioavailability of EPA and DHA from an algae oil-fortified soymilk compared with algae oil capsules

Resumen del estudio

endpoint was the change in red blood cell (RBC) EPA and DHA, with plasma and peripheral blood mononuclear cell (PBMC) profiles assessed secondarily. Both groups exhibited significantly increased EPA and DHA across all blood compartments over the 4-week intervention. Although the capsule group showed a greater unadjusted increase in RBC and plasma DHA, no significant difference in EPA or DHA accumulation remained after normalizing for dose and compliance. Therefore, fortified soymilk is a well-tolerated delivery vehicle for algae oil which increases RBC EPA and DHA offering a comparable food-based alternative to